Your browser doesn't support javascript.
loading
CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
Malagola, Michele; Radici, Vera; Farina, Mirko; Pellizzeri, Simone; Spoldi, Filippo; Morello, Enrico; Polverelli, Nicola; Buttini, Eugenia Accorsi; Bernardi, Simona; Re, Federica; Leoni, Alessandro; Signorini, Liana; Caruso, Arnaldo; Russo, Domenico.
Afiliação
  • Malagola M; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. michele.malagola@unibs.it.
  • Radici V; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Farina M; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Pellizzeri S; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Spoldi F; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Morello E; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Polverelli N; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Buttini EA; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Bernardi S; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Re F; Centro di Ricerca Emato-oncologico AIL (CREA), "ASST-Spedali Civili" Hospital, Brescia, Italy.
  • Leoni A; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Signorini L; Centro di Ricerca Emato-oncologico AIL (CREA), "ASST-Spedali Civili" Hospital, Brescia, Italy.
  • Caruso A; Blood Diseases and Cell Therapies Unit, Bone Marrow Transplant Unit, "ASST-Spedali Civili" Hospital of Brescia; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Russo D; Centro di Ricerca Emato-oncologico AIL (CREA), "ASST-Spedali Civili" Hospital, Brescia, Italy.
Bone Marrow Transplant ; 59(1): 138-140, 2024 01.
Article em En | MEDLINE | ID: mdl-37857841

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Acetatos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Infecções por Citomegalovirus / Transplante de Células-Tronco Hematopoéticas / Acetatos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article